Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
06 July 2018 Photo Supplied
Five PhDs for Chemistry group at June 2018 graduation
Pictured here are the Department of Chemistry graduates and their promoters/ co-promoters. From the left are: Dr Alebel Belay, Dr Dumisani Kama, Dr Orbett Alexander, Dr Pennie Mokolokolo and Dr Pule Molokoane; back: Prof Andreas Roodt, Dr Marietjie Schutte-Smith, Dr Alice Brink and Dr Johan Venter. Prof Roodt was either promoter or co-promoter to four of the graduates, while Prof Deon Visser (promoter; not present) and Dr Alice Brink (co-promoter) supervised Dr Orbett Alexander.
What is the common factor among metal extraction from mineral reserves, the treatment of cancer, and nanomaterials in cellular phones? The answer is Chemistry. 

For the first time since the Department of Chemistry at the University of the Free State (UFS) was founded some 114 years ago, a single research group in Chemistry delivered five PhD students.  This was achieved in the division of Inorganic Chemistry at the 2018 Winter graduation ceremony by the group under leadership of Prof Andreas Roodt and senior colleagues, Drs Johan Venter, Alice Brink and Marietjie Schutte-Smith. Prof Deon Visser, a former group member, was promoter for one of the students. 

The five graduandi are Drs Alebel Belay, Dumisani Kama, Pennie Mokolokolo, Pule Molokoane and Orbett Alexander. Their research involved the use of special chemical groups which are attached to metals such as platinum, rhodium, niobium, technetium and rhenium to create compounds with special pre-selected properties. 

The combination of these special groups with the metals allow many different potential applications – all adding value. These include metal extraction from South Africa’s rich mineral reserves, the treatment of diseases such as cancer, the diagnosis of heart and brain damages, nanomaterials which are used in cellular phones, catalysts to produce cleaner petrol, special light devices which by themselves ‘glow in the dark’, and more. 

Three of the students completed part of their research in Switzerland.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept